We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$2.66B
AUM Growth
+$11.4M
Cap. Flow
-$365M
Cap. Flow %
-13.71%
Top 10 Hldgs %
23.28%
Holding
276
New
116
Increased
46
Reduced
39
Closed
64

Sector Composition

Rank Sector Weight
1 Healthcare 14.44%
2 Technology 12.23%
3 Energy 11.54%
4 Consumer Discretionary 11.15%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRA
101
DELISTED
W.R. Grace & Co.
GRA
$5.78M 0.22%
82,409
-22,902
-22% -$1.66M
CCI icon
102
Crown Castle
CCI
$34.6B
$5.77M 0.22%
+51,981
New +$5.61M
LGF.A
103
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$5.73M 0.22%
+169,522
New +$5.33M
CL icon
104
Colgate-Palmolive
CL
$74.8B
$5.71M 0.21%
+75,700
New +$5.53M
ARCH
105
DELISTED
Arch Resources, Inc.
ARCH
$5.67M 0.21%
+60,843
New +$4.85M
RGNX icon
106
Regenxbio
RGNX
$616M
$5.43M 0.2%
163,299
-180,988
-53% -$5.45M
HST icon
107
Host Hotels & Resorts
HST
$17.5B
$5.42M 0.2%
272,738
-3,113,543
-92% -$61M
FL
108
DELISTED
Foot Locker
FL
$5.23M 0.2%
+111,508
New +$4.16M
GWPH
109
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.18M 0.19%
39,216
-21,834
-36% -$2.57M
AQUA
110
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$5.04M 0.19%
+212,750
New +$4.69M
ASND icon
111
Ascendis Pharma A/S
ASND
$16.5B
$4.99M 0.19%
+124,618
New +$4.53M
PF
112
DELISTED
Pinnacle Foods, Inc.
PF
$4.97M 0.19%
83,492
-421,760
-83% -$23.8M
NERV icon
113
Minerva Neurosciences
NERV
$191M
$4.96M 0.19%
102,418
+4,707
+5% +$233K
JACK icon
114
CALL
Jack in the Box
JACK
$314M
$4.91M 0.18%
+50,000
New +$5.09M
AGN
115
DELISTED
Allergan plc
AGN
$4.8M 0.18%
+29,371
New +$5.27M
IRTC icon
116
iRhythm Holdings
IRTC
$4.02B
$4.75M 0.18%
84,648
+26,839
+46% +$1.4M
WWE
117
DELISTED
World Wrestling Entertainment
WWE
$4.74M 0.18%
154,846
-680,493
-81% -$18.4M
RPM icon
118
RPM International
RPM
$13.8B
$4.62M 0.17%
+88,123
New +$4.61M
ETFC
119
DELISTED
E*Trade Financial Corporation
ETFC
$4.56M 0.17%
91,915
+25,914
+39% +$1.19M
ALTR
120
DELISTED
Altair Engineering Inc
ALTR
$4.46M 0.17%
+186,650
New +$4.15M
NXEO
121
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$4.43M 0.17%
486,823
-34,770
-7% -$275K
ESPR
122
DELISTED
Esperion Therapeutics
ESPR
$4.43M 0.17%
+67,241
New +$3.62M
OPTU
123
Optimum Communications Inc
OPTU
$298M
$4.4M 0.17%
+207,245
New +$4.59M
TFX icon
124
Teleflex
TFX
$5.96B
$4.39M 0.16%
+17,644
New +$4.43M
VRTS icon
125
Virtus Investment Partners
VRTS
$1.12B
$4.37M 0.16%
37,953
+6,663
+21% +$783K

Similar funds

Ascend Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Ascend Capital held 276 positions worth $2.66B, up 0.43% from $2.65B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital withdrew a net $365M in Q4 2017, closing 64 positions and reducing 39 holdings. Its most notable exit was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Energy.

Against the trend, Ascend Capital opened a new position in CVS Health worth $73.2M.

  • Ascend Capital's largest Q4 2017 buy was CVS Health: 1,009,152 shares worth $73.2M.
  • Ascend Capital added most to Waste Connections in Q4 2017, an estimated $43.4M increase.
  • Ascend Capital's biggest Q4 2017 reduction was Puma Biotechnology, cutting an estimated $65.5M.
  • Ascend Capital fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q4 2017, selling an estimated $115M.
  • Ascend Capital's ten largest holdings make up 23% of its $2.66B portfolio in Q4 2017.
  • Ascend Capital opened 116 new positions and closed 64 in Q4 2017.
  • Ascend Capital's portfolio value rose 0.43% quarter-over-quarter to $2.66B.

Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.